Skip to main content

Breadcrumb

  1. Home

Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system

Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy

Paroxysmal Nocturnal Hemoglobinuria

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Paroxysmal Nocturnal Hemoglobinuria

Examining RET Fusions

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Examining RET Fusions

NEO | AML Express™ whitepaper

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about NEO | AML Express™ whitepaper

Other resources

Submitted by admin on Wed, 12/18/2024 - 06:05
  • Read more about Other resources

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Page 90
  • Next page Next
  • Last page Last
Subscribe to